Skip to main content
Clinical Trials/JPRN-UMIN000044307
JPRN-UMIN000044307
Recruiting
未知

Japanese Alport Syndrome Patients Registry - Alport Registry

Japanese Society of Pediatric Nephrology0 sites500 target enrollmentJuly 1, 2021
ConditionsAlport syndrome

Overview

Phase
未知
Intervention
Not specified
Conditions
Alport syndrome
Sponsor
Japanese Society of Pediatric Nephrology
Enrollment
500
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2021
End Date
April 30, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Japanese Society of Pediatric Nephrology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients who have declined to provide their data when opting in consent or opting out consent 2\)Patients who have only heterozygous mutations in the COL4A3 or COL4A4 gene, urinary findings are only hematuria and no proteinuria, renal function is normal, and family history also shows only hematuria. \* To date, the definition of basement membrane thinning syndrome has not been determined, but in this study, such cases are treated as basement membrane thinning syndrome. \*\* As shown in the selection criteria 2\), if there is a patient in the family who has urinary protein or renal dysfunction and is diagnosed with autosomal dominant Alport syndrome, hematuria\-only patients are also enrolled. If you are uncertain about your decision, consult with the research office. 3\) Patients judged to be inappropriate as a target by the judgment of researchers.

Outcomes

Primary Outcomes

Not specified

Similar Trials